[Therapeutic exhaustion in patients with an implantable cardioverter-defibrillator. Are there predisposing factors?].

M Oliveira, N da Silva, E Antunes, L Sousa, P Bico, J M Conceição, J Roquette, A M Antunes
{"title":"[Therapeutic exhaustion in patients with an implantable cardioverter-defibrillator. Are there predisposing factors?].","authors":"M Oliveira,&nbsp;N da Silva,&nbsp;E Antunes,&nbsp;L Sousa,&nbsp;P Bico,&nbsp;J M Conceição,&nbsp;J Roquette,&nbsp;A M Antunes","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Unlabelled: </strong>In patients (pts) with implantable cardioverter-defibrillators (ICD), antitachycardia pacing (ATP) schemes may be used followed by a limited number of endocavitary shocks in the same episode of ventricular tachycardia (VT) with the potential risk of therapeutic exhaustion.</p><p><strong>Objective: </strong>To assess the incidence of episodes of therapeutic exhaustion in a population of ICD carriers with ATP programmes and to attempt to determine their correlation with clinical variables.</p><p><strong>Methods: </strong>Study of the episodes of VT treated by ICD in 8 patients (6 male; 2 female) with an average age of 56 +/- 17 years with a follow-up > 6 months. The underlying pathology was: ischemic heart disease-5 patients; arrhythmogenic dysplasia of the right ventricle-1 patient; hypertrophic cardiomyopathy-1 patient; and operated pulmonary valve stenosis-1 patient. The authors considered therapeutic exhaustion to be the occurrence of episodes in which VT persisted after the application of ATP and the maximum number of shocks. The patients with episodes of therapeutic exhaustion (group A-3 patients) were compared with the remaining patients (group B-5 patients) with regard to the following parameters: age; ejection fraction; previous myocardial infarction (pMI; cardiac frequency during VT (cfVT); number of episodes of non-maintained VT (NMVT) without therapeutic intervention; > 20% reduction of the VT cycle after ATP (VTATP); intensity of programmable shocks (Icho); and medication with anti-arrhythmia drugs (AA).</p><p><strong>Results: </strong>In a total of 262 VT records (duration > 2.5 sec. after detection) with treatment by ICD during an average follow-up of 11 months, 6 episodes (2.3%) of therapeutic exhaustion were detected in 3 patients. Four of the episodes occurred in the same patient in a period of 4 hours, hospitalisation being necessary following syncope. In the other two cases, there were complaints of dizziness which subsided spontaneously a short time after the application of the last shock by the ICD. [table: see text]</p><p><strong>Conclusion: </strong>Therapeutic exhaustion occurred in about 2% of the VT treated with this population. The possibility of a high number of non maintained VT episodes being associated to a greater possibility of therapeutic exhaustion may have implications on ICD programming.</p>","PeriodicalId":503648,"journal":{"name":"Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology","volume":" ","pages":"1013-20"},"PeriodicalIF":0.0000,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Unlabelled: In patients (pts) with implantable cardioverter-defibrillators (ICD), antitachycardia pacing (ATP) schemes may be used followed by a limited number of endocavitary shocks in the same episode of ventricular tachycardia (VT) with the potential risk of therapeutic exhaustion.

Objective: To assess the incidence of episodes of therapeutic exhaustion in a population of ICD carriers with ATP programmes and to attempt to determine their correlation with clinical variables.

Methods: Study of the episodes of VT treated by ICD in 8 patients (6 male; 2 female) with an average age of 56 +/- 17 years with a follow-up > 6 months. The underlying pathology was: ischemic heart disease-5 patients; arrhythmogenic dysplasia of the right ventricle-1 patient; hypertrophic cardiomyopathy-1 patient; and operated pulmonary valve stenosis-1 patient. The authors considered therapeutic exhaustion to be the occurrence of episodes in which VT persisted after the application of ATP and the maximum number of shocks. The patients with episodes of therapeutic exhaustion (group A-3 patients) were compared with the remaining patients (group B-5 patients) with regard to the following parameters: age; ejection fraction; previous myocardial infarction (pMI; cardiac frequency during VT (cfVT); number of episodes of non-maintained VT (NMVT) without therapeutic intervention; > 20% reduction of the VT cycle after ATP (VTATP); intensity of programmable shocks (Icho); and medication with anti-arrhythmia drugs (AA).

Results: In a total of 262 VT records (duration > 2.5 sec. after detection) with treatment by ICD during an average follow-up of 11 months, 6 episodes (2.3%) of therapeutic exhaustion were detected in 3 patients. Four of the episodes occurred in the same patient in a period of 4 hours, hospitalisation being necessary following syncope. In the other two cases, there were complaints of dizziness which subsided spontaneously a short time after the application of the last shock by the ICD. [table: see text]

Conclusion: Therapeutic exhaustion occurred in about 2% of the VT treated with this population. The possibility of a high number of non maintained VT episodes being associated to a greater possibility of therapeutic exhaustion may have implications on ICD programming.

植入式心律转复除颤器患者的治疗性衰竭。有诱发因素吗?
未标记:在植入心律转复除颤器(ICD)的患者(pts)中,在同一次室性心动过速(VT)发作中,可能使用抗心动过速起搏(ATP)方案,随后使用有限次数的腔内电击,有治疗衰竭的潜在风险。目的:评估ATP计划的ICD携带者中治疗衰竭发作的发生率,并试图确定其与临床变量的相关性。方法:对ICD治疗室性心动过速8例(男6例;2例女性),平均年龄56±17岁,随访> 6个月。基础病理:缺血性心脏病5例;心律失常性右心室发育不良1例肥厚性心肌病-1例;肺动脉瓣狭窄1例。作者认为治疗性衰竭是指在使用ATP和最大电击次数后仍然存在VT的发作。治疗衰竭发作患者(A-3组)与其余患者(B-5组)在以下参数方面进行比较:年龄;射血分数;既往心肌梗死(pMI;VT时心跳频率(cfVT);无治疗干预的非维持性室速(NMVT)发作次数;ATP后VT周期缩短20% (VTATP);可编程冲击强度(Icho);服用抗心律失常药物(AA)。结果:在平均随访11个月的ICD治疗的262例VT记录(检测后持续时间> 2.5秒)中,有3例患者出现治疗衰竭6次(2.3%)。其中4次发作发生在同一患者4小时内,晕厥后需住院治疗。在另外两个病例中,有头晕的主诉,在ICD施加最后一次电击后短时间内自发消退。结论:在这一人群中,治疗性衰竭发生率约为2%。大量的非维持性室速发作与治疗衰竭的可能性相关,这可能对ICD的规划有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信